Overview

Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis

Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
This study will test the safety and efficacy of AAE581 in increasing Lumbar Spine bone mineral density (BMD) at 12 months, by Dexa-scan (DXA) in postmenopausal women with osteoporosis.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis Pharmaceuticals